The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BOPA 2017 | Multidisciplinary cancer research: overcoming the odds
There is a lack of funding for research into certain cancer types, such as lung and pancreatic, compared with others. Speaking from the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK, Islam Elkonaissi of The Royal Marsden NHS Foundation Trust, London, UK, emphasizes the necessity of encouraging and supporting pharmacists, nurses and other healthcare professionals to get into research in order to overcome this obstacle.
